In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare ...

Revolution Medicines, Inc.’s RVMD share price has surged by 5.47%, which has investors questioning if this is right time to ...

Revolution Medicines, Inc. (NASDAQ:RVMD) on Sunday announced new clinical data for zoldonrasib (RMC-9805), a RAS(ON) ...

In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against other stocks ...

New clinical data for zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, demonstrates acceptable safety, tolerability, and encouraging initial antitumor activity in patients with KRAS ...

This is my first Revolution Medicines (NASDAQ:RVMD) article. Revolution is an ambitious clinical stage pharma. It has managed to generate a market cap of ~$6 billion. In common with hundreds of ...

Revolution Medicines shared Phase 1 data showing zoldonrasib's acceptable safety profile in KRAS G12D mutant solid tumors at AACR 2025.

REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS ...

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have received an average rating of “Buy” from the twelve research firms that are currently covering the stock ...

$RVMD insiders have traded $RVMD stock on the open market 32 times in the past 6 months. Of those trades, 2 have been purchases and 30 have been sales.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...